Results 91 to 100 of about 2,316 (158)

Therapeutic Potential of Peptides in Cancer Treatment: Focus on Peptide and Aptamer-Decorated Exosomes. [PDF]

Cancers (Basel)
Gangadaran P, Kumar AS, Kumaran K, Prakash K, Dhayalan S, Rajendran RL, Loganathbabu VKT, Balaji J, Baskaran R, Arun R, Karthikeyan V, Biswas S, Hong CM, ArulJothi KN, Ahn BC.   +14 more
europepmc   +1 more source

Research advances in aptamers in the diagnosis and treatment of breast cancer (Review). [PDF]

Int J Oncol
Chu L, Xiao Y, Li X, Cui J, Ma L, Shao B, Cui H.   +6 more
europepmc   +1 more source

Development of AS1411 aptamer-conjugated chitosan-carbon dot nanocarriers for targeted drug delivery and fluorescent imaging in breast cancer therapy. [PDF]

J Biol Eng
Mantashlou MJ, Alizadeh E, Moghaddam SV, Afshari NS, Noorbakhsh A.   +4 more
europepmc   +1 more source

Fulfilling multiple roles in PROTAC design: The emerging potential of oligonucleotides. [PDF]

Eur J Med Chem
Rodrigues DA, Pires GS, Roy U, Conway E, de Sena Murteira Pinheiro P.   +4 more
europepmc   +1 more source

Quantitative oncogene-mapping within malignant tumors through Multi-parameter MRI based on RNA-triggered nanoprobes. [PDF]

Mater Today Bio
Li W, Wang R, Zhang X, Wu S, Zhang P, Feng H, Lan Y, Ao Z, Hou Y.   +8 more
europepmc   +1 more source

Tumor-targeted aptamer-conjugated engineered bacteria for CXCL9 cytokine delivery in non-small cell lung cancer immunotherapy. [PDF]

J Transl Med
Gu Q, Wang R, Zhang L, Pan D, Bian C, Jia E, Chang J, Zhang H.   +7 more
europepmc   +1 more source

Aptamer-liposome targeted nanotherapeutics for cancer therapy: Bibliometric analysis, recent developments and future perspectives. [PDF]

Mater Today Bio
Gao Z, Du S, Song J, Gao Y, Peng X, Lin X, E S, Zhao Y, Zhang S.   +8 more
europepmc   +1 more source

Human Serum Albumin as a Prodrug Carrier for Tumor Therapy: Mechanisms, Applications, and Future Perspectives. [PDF]

Pharmaceutics
Shang Y, Wang S, Yan Y, Tian E, She L, Ma Z.   +5 more
europepmc   +1 more source

Enhancing the intracellular delivery of antisense oligonucleotides (ASO) : a comparative study of aptamer, vitamin E, and cholesterol ASO conjugates. [PDF]

RSC Adv
Balachandran AA, Poudel BH, Rahimizadeh K, Chikkanna A, Veedu RN.   +4 more
europepmc   +1 more source

Aptamers and aptamer-drug conjugates as synthetic immune modulators for cancer immunotherapy. [PDF]

Front Immunol
Arshad F, Chinnappan R, Mir TA, Ahmed Z, Arora I, Khan MI, Yaqinuddin A.   +6 more
europepmc   +1 more source